MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

MeiraGTx Holdings plc ( NASDAQ:MGTX ) is possibly approaching a major achievement in its business, so we would like ...

Damian Lewis cosied up to girlfriend Alison Mosshart at Masterpiece's Wolf Hall: The Mirror and the Light special screening ...

MeiraGTx (NASDAQ:MGTX – Get Free Report) had its price objective raised by Royal Bank of Canada from $11.00 to $13.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has ...

In comes, DeepSeek, a Chinese AI startup that has shown it is possible to develop AI models without spending much. It ...

RBC Capital raised the firm’s price target on MeiraGTx (MGTX) to $13 from $11 and keeps an Outperform rating on the shares after its Q4 ...

Why have BMS investors been anything but positive about acquiring 2seventy? The answer stems from uncertainty over how ...

MeiraGTx Holdings plc has recently released its 10-K report, offering insight into the company's financial condition and ...

MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...

UiPath Inc. PATH was down, falling 16% to $10.00 after the company reported a fourth-quarter revenue miss and issued ...

Hologen is paying MeiraGTx $200 million upfront and committing $230 million to fund Hologen Neuro AI and a Parkinson's disease gene therapy.